History | Abdominal aortic aneurysm: diagnosis and management | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Committee list updated

Committee member list (PDF 139 KB)

Published:

19 March 2020

Declaration of interests

Register of interests (PDF 187 KB)

Published:

19 March 2020

Guidance published

Equality impact assessment 4 (PDF 108 KB)

Published:

19 March 2020
Consultation comments and responses (PDF 8.42 MB)

Published:

19 March 2020
Supporting documentation - acknowledgements (PDF 200 KB)

Published:

19 March 2020

Stakeholder list updated

Stakeholder list (PDF 199 KB)

Published:

17 March 2020

Draft guidance consultation

Draft guidance consultation
Supporting documentation - algorithm (PDF 432 KB)

Published:

16 May 2018
Supporting documentation - health economics appendix (PDF 8.62 MB)

Published:

16 May 2018
Supporting documentation - methods section (PDF 356 KB)

Published:

16 May 2018
Supporting documentation - acknowledgements (PDF 254 KB)

Published:

16 May 2018
Short version of draft guideline (PDF 619 KB)

Published:

16 May 2018
Evidence review A (PDF 2.93 MB)

Published:

16 May 2018
Evidence review B (PDF 1.88 MB)

Published:

16 May 2018
Evidence review C (PDF 1.16 MB)

Published:

16 May 2018
Evidence review D (PDF 746 KB)

Published:

16 May 2018
Evidence review E (PDF 1.09 MB)

Published:

16 May 2018
Evidence review F (PDF 1.17 MB)

Published:

16 May 2018
Evidence review G (PDF 1.02 MB)

Published:

16 May 2018
Evidence review H (PDF 1.14 MB)

Published:

16 May 2018
Evidence review I (PDF 539 KB)

Published:

16 May 2018
Evidence review J (PDF 1.57 MB)

Published:

16 May 2018
Evidence review K (PDF 1.96 MB)

Published:

16 May 2018
Evidence review L (PDF 1.83 MB)

Published:

16 May 2018
Evidence review M (PDF 1.01 MB)

Published:

16 May 2018
Evidence review N (PDF 471 KB)

Published:

16 May 2018
Evidence review O (PDF 416 KB)

Published:

16 May 2018
Evidence review P (PDF 507 KB)

Published:

16 May 2018
Evidence review Q (PDF 478 KB)

Published:

16 May 2018
Evidence review R (PDF 427 KB)

Published:

16 May 2018
Evidence review S (PDF 1.47 MB)

Published:

16 May 2018
Evidence review T (PDF 1.64 MB)

Published:

16 May 2018
Evidence review U (PDF 474 KB)

Published:

16 May 2018
Evidence review V (PDF 581 KB)

Published:

16 May 2018
Evidence review W (PDF 4.14 MB)

Published:

16 May 2018
Evidence review X (PDF 615 KB)

Published:

16 May 2018
Equality impact assessment (PDF 270 KB)

Published:

16 May 2018
Comments form (MSWord 62 KB)

Published:

01 June 2018

Pre-consultation documents released

Economic plan (PDF 144 KB)

Published:

28 March 2018
Search strategies (PDF 744 KB)

Published:

28 March 2018
Review questions (PDF 226 KB)

Published:

28 March 2018

Committee meetings

Committee meeting
Minutes 1 (PDF 256 KB)

Published:

03 November 2015
Minutes 2 (PDF 258 KB)

Published:

15 December 2015
Minutes 3 (PDF 289 KB)

Published:

26 January 2016
Minutes 4 (PDF 248 KB)

Published:

08 March 2016
Minutes 6 (PDF 349 KB)

Published:

07 June 2016
Minutes 7 (PDF 228 KB)

Published:

26 July 2016
Minutes 8 (PDF 240 KB)

Published:

13 September 2016
Minutes 9 (PDF 286 KB)

Published:

11 April 2017
Minutes 10 (PDF 291 KB)

Published:

22 May 2017
Minutes 11 (PDF 324 KB)

Published:

03 July 2017
Minutes 12 (PDF 316 KB)

Published:

05 October 2017
Minutes 13 (PDF 278 KB)

Published:

06 November 2017
Minutes 14 (PDF 278 KB)

Published:

18 December 2017
Minutes 15 (PDF 192 KB)

Published:

29 January 2018
Minutes 16 (PDF 143 KB)

Published:

25 July 2018
Minutes 17 (PDF 145 KB)

Published:

28 February 2019

Equality and health inequalities assessment

Equality impact assessment 1 (PDF 82 KB)

Published:

13 July 2016
Equality impact assessment 2 (PDF 158 KB)

Published:

13 July 2016

Consultation comments published

Consultation comments and responses (PDF 223 KB)

Published:

03 November 2015

Scope published

Final scope (PDF 210 KB)

Published:

02 November 2015

Abdominal aortic aneurysm: the scope

Abdominal aortic aneurysm: consultation on the draft scope information
Abdominal aortic aneurysm: draft scope for consultation
Abdominal aortic aneurysm: draft scope for consultation (PDF 219 KB)

Published:

25 August 2015
Abdominal aortic aneurysm: equalities impact assessment - scoping
Abdominal aortic aneurysm: equalities impact assessment - scoping (PDF 163 KB)

Published:

25 August 2015